Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Exchange Rate Effect: 2020-2025

Historic Exchange Rate Effect for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $287,000.

  • Cellebrite DI's Exchange Rate Effect rose 116.12% to $287,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$154,000, marking a year-over-year increase of 88.64%. This contributed to the annual value of -$1.2 million for FY2024, which is 304.92% down from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Exchange Rate Effect is $287,000, which was up 159.67% from -$481,000 recorded in Q1 2025.
  • Cellebrite DI's Exchange Rate Effect's 5-year high stood at $1.8 million during Q4 2024, with a 5-year trough of -$1.8 million in Q3 2024.
  • Moreover, its 3-year median value for Exchange Rate Effect was -$90,500 (2023), whereas its average is $17,700.
  • As far as peak fluctuations go, Cellebrite DI's Exchange Rate Effect plummeted by 1,666.67% in 2022, and later soared by 429.43% in 2023.
  • Over the past 5 years, Cellebrite DI's Exchange Rate Effect (Quarterly) stood at $955,000 in 2021, then plummeted by 113.93% to -$133,000 in 2022, then slumped by 611.28% to -$946,000 in 2023, then soared by 292.39% to $1.8 million in 2024, then spiked by 116.12% to $287,000 in 2025.
  • Its last three reported values are $287,000 in Q3 2025, -$481,000 for Q1 2025, and $1.8 million during Q4 2024.